Lin Xiaoqi, Zhou Yanyu, Ye Lina, Wang Baoshan, Jiao Yingfu, Yu Weifeng, Gao Po, Yang Liqun
Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education, China.
Heliyon. 2023 Nov 19;9(11):e22644. doi: 10.1016/j.heliyon.2023.e22644. eCollection 2023 Nov.
Hepatic ischemia-reperfusion injury (HIRI) is a complex pathological phenomenon dominated by the innate immune system and involves a variety of immune cells. This condition frequently occurs during hepatectomy, liver transplantation or hemorrhagic shock. HIRI represents an important factor in the poor prognosis of patients after liver surgery. However, there is still a lack of effective intervention to reduce the incidence of HIRI. In this study, we aimed to describe the overall structure of scientific research on HIRI over the past 20 years and provide valuable information and guidelines for future researchers. Bibliometric analysis was used to comprehensively review developments in HIRI and changes in our understanding of HIRI over the past two decades. We identified a total of 4267 articles on HIRI that were published over the past 20 years of which basic research was predominant. Collaboration network analysis revealed that China, the University of California Los Angeles, and Ronald W Busuttil were the most influential country, institute, and scholar, respectively. Co-occurrence cluster analysis revealed that ischemic preconditioning, liver cirrhosis, hepatic I/R injury, autophagy, acute liver failure, oxygen, donation after circulatory death, Nlrp3, remote organ, and microdialysis were the top 10 clusters. Keyword burst detection indicated that autophagy, inflammation, and early allograft dysfunction represent the current research hotspots. In summary, this is the first bibliometric analysis of HIRI research. Our timely analysis of these hotpots and research trends may provide a framework for future researchers and further promote research on the key mechanisms and therapeutic measures in this field.
肝缺血再灌注损伤(HIRI)是一种以先天免疫系统为主导的复杂病理现象,涉及多种免疫细胞。这种情况经常发生在肝切除术、肝移植或失血性休克期间。HIRI是肝脏手术后患者预后不良的一个重要因素。然而,目前仍缺乏有效的干预措施来降低HIRI的发生率。在本研究中,我们旨在描述过去20年中关于HIRI的科学研究的整体结构,并为未来的研究人员提供有价值的信息和指导方针。文献计量分析被用于全面回顾过去二十年中HIRI的发展以及我们对HIRI理解的变化。我们共确定了过去20年发表的4267篇关于HIRI的文章,其中基础研究占主导地位。合作网络分析显示,中国、加利福尼亚大学洛杉矶分校和罗纳德·W·布苏蒂尔分别是最具影响力的国家、机构和学者。共现聚类分析显示,缺血预处理、肝硬化、肝脏缺血/再灌注损伤、自噬、急性肝衰竭、氧气、循环死亡后捐赠、Nlrp3、远程器官和微透析是前10个聚类。关键词突现检测表明,自噬、炎症和早期移植物功能障碍是当前的研究热点。总之,这是首次对HIRI研究进行文献计量分析。我们对这些热点和研究趋势的及时分析可能为未来的研究人员提供一个框架,并进一步推动该领域关键机制和治疗措施的研究。
Hepatobiliary Pancreat Dis Int. 2023-2
Am J Physiol Gastrointest Liver Physiol. 2022-9-1
Acc Chem Res. 2024-9-3
Front Med (Lausanne). 2022-11-15
Front Endocrinol (Lausanne). 2022
Front Immunol. 2022